Here we go again! Which girl is your favorite? Tila Tequila doesn’t count cause she’s a pro lol!
| Click to vote for me! |
Here we go again! Which girl is your favorite? Tila Tequila doesn’t count cause she’s a pro lol!
| Click to vote for me! |
Don’t forget that this weekend these girls want to meet you! Then empty your wallet and hook up with another guy! BITCHES! LOL!
| Click to vote for me! |
Elisha Cuthbert was in The Girl Next Door as every teen guy’s sexy dream girl. She really knows how to work it!
| Click to vote for me! |
Do hot girls make the world go round? I know these girls are helping me in more ways than one haha!
| Click to vote for me! |
« Topic Nexavar Approved For Liver Cancer (healthday) | Main | Topic Timely Cancer Diagnosis Linked To Insurance Status (healthday) »
By admin2 | April 28, 2008
Results from a Phase III study demonstrate that significantly more patients who received GlaxoSmithKline’s investigational monoclonal antibody, Bosatria® (mepolizumab), for the treatment of hypereosinophilic syndrome (HES), were able to maintain control of their disease with a reduced dose of a corticosteroid, compared to those who received placebo (84% vs. 43%, p
(Link)
Topics: Cancer |